n.颅咽管瘤

A craniopharyngioma is a slow-growing tumor that develops from cells remaining in the sella turcica after birth.
这是一种生长缓慢的肿瘤，源自出生后留在蝶鞍内的细胞。
The patient was diagnosed with a suprasellar craniopharyngioma, which had caused visual disturbances and hormonal imbalances.
患者被诊断为垂体上方的颅咽管瘤，导致视觉障碍和激素失衡。
Treatment for craniopharyngiomas often involves surgery, radiation therapy, or a combination of both to remove or shrink the tumor.
颅咽管瘤的治疗通常包括手术、放射疗法或两者的组合，以移除或缩小肿瘤。
Despite aggressive treatment, some craniopharyngiomas may recur, necessitating further interventions.
即使经过积极治疗，某些颅咽管瘤可能复发，需要进一步处理。
Craniopharyngiomas can affect children as well as adults, and symptoms may vary depending on the location and size of the tumor.
颅咽管瘤可以影响儿童和成人，症状可能会根据肿瘤的位置和大小而变化。
In rare cases, craniopharyngiomas can lead to hydrocephalus, a buildup of cerebrospinal fluid in the brain.
在极少数情况下，颅咽管瘤可能导致脑积水，即大脑中脑脊液的积聚。
Postoperative care for patients with craniopharyngiomas often includes monitoring for complications such as hormone deficiencies or vision problems.
对于接受颅咽管瘤手术的患者，术后护理通常包括监测可能出现的并发症，如激素缺乏或视力问题。
The long-term prognosis for individuals with craniopharyngiomas depends on the effectiveness of treatment and any residual effects on brain function.
患有颅咽管瘤的人的长期预后取决于治疗效果以及对大脑功能的任何残留影响。
Some craniopharyngiomas produce hormones, leading to endocrine disorders like Cushing's syndrome or acromegaly.
有些颅咽管瘤会产生激素，导致内分泌失调，如库欣综合症或肢端肥大症。
Researchers continue to investigate new therapeutic approaches for managing craniopharyngiomas, including targeted drug therapies and immunotherapies.
研究人员继续研究新的治疗颅咽管瘤的方法，包括靶向药物疗法和免疫疗法。